Japan, Nov. 10 -- REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'CRISPR/CAS SCREENING PLATFORM TO IDENTIFY GENETIC MODIFIERS OF TAU SEEDING OR AGGREGATION.' Other related details are as follows:
Application Number: JP,2024-046338
Category (FI): C12N15/11@Z,C12N5/10,C12Q1/6869@Z,C12N15/09,110,C12Q1/02,C40B40/06,C12Q1/68
Stage: Grant (IP right document published.)
Filing Date: March 22, 2024
Publication Date: May 24, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
